Actively Recruiting
Tumor-Lymph Node Mapping
Led by University of Rochester · Updated on 2026-04-23
10
Participants Needed
1
Research Sites
119 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.
CONDITIONS
Official Title
Tumor-Lymph Node Mapping
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients under 18 years of age treated at University of Rochester Medical Center, Department of Surgery
- Diagnosed with a pediatric solid tumor
- Scheduled for lymph node sampling as part of clinical care
You will not qualify if you...
- History of iodide allergies
- Inability or unwillingness to provide written informed consent by participant or parent/legal guardian
- Currently pregnant
- Infants weighing less than 650 grams
- Extensive prior surgery at the primary tumor site or nodal basin expected to affect lymphatic drainage
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Rochester Medical Center
Rochester, New York, United States, 14642
Actively Recruiting
Research Team
A
Abdelhafeez Abdelhafeez, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here